Cargando…
T2 mapping of molecular subtypes of WHO grade II/III gliomas
BACKGROUND: According to the new WHO classification from 2016, molecular profiles have shown to provide reliable information about prognosis and treatment response. The purpose of our study is to evaluate the diagnostic potential of non-invasive quantitative T2 mapping in the detection of IDH1/2 mut...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947951/ https://www.ncbi.nlm.nih.gov/pubmed/31914945 http://dx.doi.org/10.1186/s12883-019-1590-1 |